We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.93%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.42B
AUM Growth
+$6M
(+0.18%)
Cap. Flow
-$56.5M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
23.69%
Holding
516
New
65
Increased
98
Reduced
233
Closed
68
Avg Time Held
1.4
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$65.1M |
| 2 |
Las Vegas Sands
LVS
|
+$37.7M |
| 3 |
Thor Industries
THO
|
+$34.6M |
| 4 |
Lear
LEA
|
+$33.5M |
| 5 |
Idexx Laboratories
IDXX
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Campbell Soup
CPB
|
+$60.2M |
| 2 |
Lowe's Companies
LOW
|
+$57.7M |
| 3 |
Clorox
CLX
|
+$44.5M |
| 4 |
Darden Restaurants
DRI
|
+$39.4M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$37.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 16.69% |
| 4 | Industrials | 13.06% |
| 5 | Consumer Staples | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DF
226
DELISTED
Dean Foods Company
DF
| $289K | 0.01% |
13,286
+4,540
| +52% | +$86.3K |
2015 Q4
4 quarters
|
|
227
Vanda Pharmaceuticals
VNDA
$244M
| $287K | 0.01% |
18,020
-2,910
| -14% | -$46.8K |
2016 Q3
1 quarter
|
|
228
Halozyme
HALO
$13.7B
| $279K | 0.01% |
28,200
| – | – |
2015 Q3
5 quarters
|
|
229
Green Dot
GDOT
$696M
| $271K | 0.01% |
11,528
+3,940
| +52% | +$92.2K |
2016 Q3
1 quarter
|
|
230
DELISTED
Radius Health, Inc.
RDUS
| $264K | 0.01% |
6,950
| – | – |
2016 Q1
3 quarters
|
|
231
DELISTED
Exact Sciences
EXAS
| $258K | 0.01% |
19,340
| – | – |
2016 Q2
2 quarters
|
|
|
ARGO
232
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $256K | 0.01% |
4,471
| – | – |
2016 Q2
2 quarters
|
|
233
Sarepta Therapeutics
SRPT
$1.8B
| $254K | 0.01% |
+9,260
| New | +$372K |
2016 Q4
0 quarters
|
|
234
Ternium
TX
$11.2B
| $249K | 0.01% |
10,305
-100
| -1% | -$2.33K |
2016 Q2
2 quarters
|
|
235
Myriad Genetics
MYGN
$386M
| $240K | 0.01% |
14,400
-100
| -0.7% | -$1.81K |
2015 Q4
4 quarters
|
|
|
SHI
236
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $240K | 0.01% |
4,443
-100
| -2% | -$5.19K |
2016 Q1
3 quarters
|
|
237
Dana Inc
DAN
$3.12B
| $231K | 0.01% |
12,161
+4,170
| +52% | +$69.8K |
2015 Q1
7 quarters
|
|
238
Kyntra Bio
KYNB
$20.4M
| $226K | 0.01% |
423
-4
| -0.9% | -$2K |
2015 Q3
5 quarters
|
|
|
ALDR
239
DELISTED
Alder Biopharmaceuticals
ALDR
| $224K | 0.01% |
10,760
| – | – |
2016 Q2
2 quarters
|
|
240
WPP
WPP
$5.87B
| $223K | 0.01% |
+2,019
| New | +$219K |
2016 Q4
0 quarters
|
|
241
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$155B
| $222K | 0.01% |
29,043
-300
| -1% | -$2.18K |
2013 Q2
14 quarters
|
|
242
Trane Technologies
TT
$101B
| $220K | 0.01% |
2,931
| – | – |
2016 Q2
2 quarters
|
|
243
DELISTED
KEMET Corporation
KEM
| $220K | 0.01% |
+33,190
| New | +$159K |
2016 Q4
0 quarters
|
|
244
Amphastar Pharmaceuticals
AMPH
$1.1B
| $214K | 0.01% |
11,620
-370
| -3% | -$7.2K |
2015 Q4
4 quarters
|
|
245
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| $214K | 0.01% |
13,015
-200
| -2% | -$3.29K |
2015 Q4
4 quarters
|
|
246
Open Text
OTEX
$6.16B
| $212K | 0.01% |
6,870
| – | – |
2016 Q2
2 quarters
|
|
247
Copa Holdings
CPA
$5.41B
| $211K | 0.01% |
+2,322
| New | +$210K |
2016 Q4
0 quarters
|
|
248
Ferrari
RACE
$69.5B
| $211K | 0.01% |
+3,635
| New | +$198K |
2016 Q4
0 quarters
|
|
249
Canadian Imperial Bank of Commerce
CM
$102B
| $210K | 0.01% |
5,140
| – | – |
2016 Q3
1 quarter
|
|
250
RELX
RELX
$67.7B
| $208K | 0.01% |
11,572
-100
| -0.9% | -$1.77K |
2014 Q4
8 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Smith Group Asset Management held 516 positions worth $3.42B, up 0.18% from $3.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Smith Group Asset Management's Q4 2016 filing shows 65 new, 98 increased, 233 reduced and 68 closed positions. Its largest new stake was Las Vegas Sands: 646,630 shares worth $34.5M. The largest sale was Campbell Soup, an estimated $60.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q4 2016 buy was Las Vegas Sands: 646,630 shares worth $34.5M.
- Smith Group Asset Management added most to Target in Q4 2016, an estimated $65.1M increase.
- Smith Group Asset Management's biggest Q4 2016 reduction was Clorox, cutting an estimated $44.5M.
- Smith Group Asset Management fully exited Campbell Soup in Q4 2016, selling an estimated $60.2M.
- Smith Group Asset Management's ten largest holdings make up 24% of its $3.42B portfolio in Q4 2016.
- Smith Group Asset Management opened 65 new positions and closed 68 in Q4 2016.
- Smith Group Asset Management's portfolio value rose 0.18% quarter-over-quarter to $3.42B.
Based on Smith Group Asset Management's 13F filing for Q4 2016, filed 31 Jan 2017.